Newly issued HCPCS Code from the Centers for Medicare and Medicaid Services (CMS) addresses widespread adoption and use of the artificial intelligence (AI)-enabled EchoGo® heart failure device (Ultromics) to assist in the detection of ejection-preserved heart failure may facilitate reimbursement for Fraction (HFpEF).
According to CMS, clinicians can take advantage of the HCPCS code (C9786), effective July 1, 2023, for “computer-aided detection” of HFpEF based on echocardiographic imaging.1 Ultromics noted that the HCPCS code is designated for outpatient use of the EchoGo® heart failure device for Medicare beneficiaries.
“This is a major milestone that will allow hospitals to accelerate the adoption of EchoGo heart failure to improve detection of HFpEF within their systems,” said Dr. Ross Upton, CEO and founder of Ultromics. rice field. “Given the prevalence of HFpEF, this is an important advance towards recognizing and detecting a highly underdiagnosed condition.”
EchoGo Heart Failure, which received FDA 510(k) clearance in December 2022, automatically detects HFpEF through single-view AI assessment of echocardiograms, according to Ultromics.2 The company noted that a recently published study demonstrated a sensitivity rate of 87.8 percent and a specificity of 83 percent for EchoGo heart failure in diagnosing HFpEF.3,4
References
1. Ultromics. CMS establishes his HCPCS code for Ultromics EchoGo heart failure, accelerating access to high-precision HFpEF detection. Available at: https://www.prnewswire.com/news-releases/cms-establishes-hcpcs-code-for-ultromics-echogo-heart-failure-accelerated-access-to-precision-hfpef-detection-301869759. html. Published July 5, 2023. Accessed July 6, 2023.
2. Hall J. FDA approves AI-powered echocardiography platform to preserve ejection fraction and detect heart failure. Diagnostic imaging. Available at: https://www.diagnosticimaging.com/view/fda-clears-ai-powered-echocardiography-platform-for-detecting-heart-failure-with-preserved-ejection-fraction . Published December 7, 2022. Accessed July 6, 2023.
3. Nikorowitsch J, Bei der Kellen J, Kirchhof P, et al. We apply the ejection fraction-preserving heart failure diagnostic algorithms of ESC 2016, H2 FPEF, and HFA-PEFF to the general population. ESC heart failure. 2021;8(5):3603-3612.
4. Sanders-van Wijk S, Aizpurua AB, Brunner-La Rocca HP, et al. The HFA-PEFF score and his H2FPEF score have little agreement in classifying patients with suspected heart failure with preserved ejection fraction. Eur J heart failure. 2021;23(5):838-840.
